Igny, France

Nicolas Ducrot

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Université Paris-Saclay. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolas Ducrot. Retrieved from https://idiyas.com/inventor/nicolas-ducrot-o0j5zzr4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicolas Ducrot: Innovator in Nanoparticle Technology

Introduction

Nicolas Ducrot is a prominent inventor based in Igny, France. He has made significant contributions to the field of nanoparticle technology, particularly through his innovative research and patents. His work focuses on the production and functionalization of nanoparticles derived from phage T5, which have therapeutic uses.

Latest Patents

Nicolas Ducrot holds a patent titled "Production and Functionalization of Nanoparticles Derived from Phage T5 and Therapeutic Uses." This patent highlights his expertise in developing advanced nanoparticle applications that can potentially revolutionize therapeutic methods.

Career Highlights

Throughout his career, Ducrot has been associated with esteemed institutions such as Université Paris-Saclay and the Centre National de la Recherche Scientifique. His work at these organizations has allowed him to explore innovative solutions in the field of nanotechnology.

Collaborations

Ducrot has collaborated with notable colleagues, including Pascale Boulanger and Karim Benihoud. These partnerships have further enriched his research and contributed to the advancement of nanoparticle technology.

Conclusion

Nicolas Ducrot's contributions to nanoparticle technology and his innovative patent demonstrate his commitment to advancing scientific research. His work continues to inspire future developments in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…